Project description:Facioscapulohumeral muscular dystrophy (FSHD) is the second most common genetic myopathy, characterized by slowly progressing and highly heterogeneous muscle wasting with a typical onset in the late teens/early adulthood [1]. Although the etiology of the disease for both FSHD type 1 and type 2 has been attributed to gain-of-toxic function stemming from aberrant DUX4 expression, the exact pathogenic mechanisms involved in muscle wasting have yet to be elucidated [2-4]. The 2021 FSHD International Research Congress, held virtually on June 24-25, convened over 350 researchers and clinicians to share the most recent advances in the understanding of the disease mechanism, discuss the proliferation of interventional strategies and refinement of clinical outcome measures, including results from the ReDUX4 trial, a phase 2b clinical trial of losmapimod in FSHD [NCT04003974].

| S-EPMC8762812 | biostudies-literature

Abstracts of the XIX International Congress of Neuropathology, Tokyo, Japan, September 23-27, 2018.

Project description: Not available

| S-EPMC8028628 | biostudies-literature

Proceedings of Reanimation 2021, the French Intensive Care Society International Congress.

Project description: Not available

| S-EPMC8239334 | biostudies-literature

ERS International Congress 2021: highlights from the Respiratory Intensive Care Assembly.

Project description:Early Career Members of Assembly 2 (Respiratory Intensive Care) attended the European Respiratory Society International Congress through a virtual platform in 2021. Sessions of interest to our assembly members included symposia on the implications of acute respiratory distress syndrome phenotyping on diagnosis and treatment, safe applications of noninvasive ventilation in hypoxaemic respiratory failure, and new developments in mechanical ventilation and weaning, and a guidelines session on applying high-flow therapy in acute respiratory failure. These sessions are summarised in this article.

| S-EPMC9124870 | biostudies-literature

ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly.

Project description:This article provides an overview of scientific highlights in the field of interstitial lung disease (ILD), presented at the virtual European Respiratory Society Congress 2021. A broad range of topics was discussed this year, ranging from translational and genetic aspects to novel innovations with the potential to improve the patient pathway. Early Career Members summarise a selection of interesting findings from different congress sessions, together with the leadership of Assembly 12 - Interstitial Lung Disease.

| S-EPMC9124869 | biostudies-literature

Abstracts of the 20<sup>th</sup> International Congress of Neuropathology Berlin, Germany, September 13 - 16, 2023.

Project description: Not available

| S-EPMC10483180 | biostudies-literature